Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth hormone secretagogue receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | rhodopsin-like orphan GPCR | growth hormone secretagogue receptor | 289 aa | 243 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | solute carrier family 2, facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Leishmania major | glucose transporter/membrane transporter D2, putative | 0.0037 | 0.1693 | 0.5 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma cruzi | hexose transporter, putative | 0.0037 | 0.1693 | 1 |
Trypanosoma brucei | glucose transporter 1E | 0.0037 | 0.1693 | 0.5 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0119 | 1 | 0.5 |
Loa Loa (eye worm) | sugar transporter | 0.0119 | 1 | 0.5 |
Leishmania major | glucose transporter, lmgt3 | 0.0037 | 0.1693 | 0.5 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Plasmodium falciparum | hexose transporter | 0.0119 | 1 | 0.5 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Schistosoma mansoni | glucose transport protein | 0.0119 | 1 | 0.5 |
Plasmodium vivax | hexose transporter | 0.0119 | 1 | 0.5 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0119 | 1 | 1 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Trypanosoma cruzi | hexose transporter, putative | 0.0037 | 0.1693 | 1 |
Schistosoma mansoni | glucose transport protein | 0.0119 | 1 | 0.5 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0119 | 1 | 1 |
Leishmania major | glucose transporter, lmgt2 | 0.0037 | 0.1693 | 0.5 |
Trypanosoma cruzi | hexose transporter | 0.0037 | 0.1693 | 1 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Trypanosoma cruzi | hexose transporter, putative | 0.0037 | 0.1693 | 1 |
Leishmania major | glucose transporter, lmgt1 | 0.0037 | 0.1693 | 0.5 |
Trypanosoma brucei | glucose transporter 2A | 0.0037 | 0.1693 | 0.5 |
Schistosoma mansoni | glucose transport protein | 0.0119 | 1 | 0.5 |
Toxoplasma gondii | facilitative glucose transporter GT1 | 0.0119 | 1 | 0.5 |
Trypanosoma brucei | glucose transporter, putative | 0.0037 | 0.1693 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 65 nM | Displacement of 125I-[His9]-ghrelin from human GHSR1a expressed in LLC-PK1 cells by competitive binding assay | ChEMBL. | 25435152 |
IC50 (binding) | = 1210 nM | Antagonist activity at human GSHR1a expressed in mouse LTK cells assessed as inhibition of ghrelin-induced reporter gene expression after 6 hrs by CRE/luciferase reporter gene assay | ChEMBL. | 25435152 |
IC50 (binding) | = 2115 nM | Antagonist activity at GHSR1a (unknown origin) assessed as inhibition of ghrelin-induced intracellular calcium mobilization | ChEMBL. | 25435152 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.